Duke Health Establishes New Endowed Clinical Directorship in Cancer Care
Dr. Diane Reidy-Lagunes is the first person to be named inaugural Joseph O. Moore, MD, Director in Oncology, with$2.5 million anonymous gift.
Thirteen Medicine Faculty Members Receive 2025 Excellence in Education Awards
The Department of Medicine recognizes 13 faculty members with 2025 Excellence in Education Awards in recognition of their outstanding work and dedication to the education of its fellows, residents and students.
Drs. Lorsch, Zhou Receive 2025 ASCI Young Physician-Scientist Awards
Gastroenterology fellow Zachary S. Lorsch, and Katherine Zhao, a hematology-oncology fellow in the Duke Department of Medicine (DOM) are recipients of the American Society for Clinical Investigation (ASCI) 2025 Early-Career Awards.
Dr. Sanghee Hong Receives 2025 American Society of Hematology Scholar Award
Dr. Sanghee Hong, assistant professor in the Division of Hematologic Malignancies and Cellular Therapy, is among 35 recipients of the 2025 American Society of Hematology (ASH) Scholar awards.
Leadership Spotlight: Dr. Stefanie Sarantopoulos is Bringing Science and Clinicians Together
Dr. Stefanie Sarantopoulos grew up in the Connecticut textile mill town of Danielson, where her Greek immigrant grandparents settled. When she was 12, her parents moved the family across the country to open a restaurant in rural Arizona—the Olympic Pizzarama—where Dr. Sarantopoulos discovered how much she loved people—and their stories.
Fellow Dr. Allison Taylor: Improving Access of Care for Under-presented Patients with Hematologic Diseases
First-year hematology/oncology fellow Allison Taylor, MD, is a first-generation Ghanaian-American who grew up in Accra, Ghana, where she became interested in hematologic malignancies after a family member died from non-Hodgkin’s lymphoma at the age of 25.
Dr. Stefanie Sarantopoulos Named Division Chief of Hematologic Malignancies and Cellular Therapy
Stefanie Sarantopoulos, MD, PhD, has been named division chief for the Division of Hematologic Malignancies and Cellular Therapy (HMCT), effective January 1, 2024.
Continuing Medical Education: A Pathway to Collaboration and Inspiration
The Duke Department of Medicine (DOM) has long been at the forefront of advancing medical knowledge and fostering collaboration through its Continuing Medical Education (CME) efforts. With a focus on two pivotal programs— Medicine Grand Rounds (MGR) and the Learning Education and Discussion Series (LEADS) —the department not only ensures the maintenance of professional licenses but also cultivates an environment of shared learning, innovation, and inspiration.
MGR: A Legacy of Innovation
Moving Medicine Forward: Dr. Shariff Receives Community Cancer Centers Innovators Award
Afreen Shariff, MD, assistant professor in the division of Endocrinology, Metabolism and Nutrition, has been selected by the Association of Community Cancer Centers (ACCC) as a 2023 Innovator Award recipient for her work on the effectiveness of electronic consults for immune-related endocrine toxicities.
Transformational Leader Quinn Capers, MD, to Deliver June 16 Greenfield Lecture
Academic medicine transformation leader Quinn Capers, IV, MD, the Rody P. Cox Professor of Internal Medicine (Cardiology) and associate dean for faculty at the University of Texas Southwest School of Medicine, will deliver the June 16 Greenfield lecture.
The event will be held in person only beginning at 8 a.m. in Duke North, 2002. Breakfast will be served outside of the room starting at 7:45am.